Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP)

NCT05968391 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-06-03

No results posted yet for this study

Summary

The objective of this study is to nake a comparison between 11c-acetate and 11c-acetoacetate kidney uptake in chronic kidney failure patients.

Conditions

  • Kidney Failure, Chronic

Interventions

RADIATION

PET scan metabolic day

11C-Acetate and 11C-Acetoacetate PET scans

Sponsors & Collaborators

  • Nestle Health Science

    collaborator INDUSTRY
  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Mélanie Godin, MD · Université de Sherbrooke

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-02
Primary Completion
2024-12-15
Completion
2025-06-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05968391 on ClinicalTrials.gov